ALIMERA SCIENCES INC (ALIM) Forecast, Price Target & Analyst Ratings
NASDAQ:ALIM • US0162592028
5.54 USD
-0.01 (-0.18%)
At close: Sep 13, 2024
5.54 USD
0 (0%)
After Hours: 9/13/2024, 8:00:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALIMERA SCIENCES INC (ALIM).
Forecast Snapshot
Consensus Price Target
$5.78
+ 4.33% Upside
Next Earnings Forecast
Release DateOct 24, 2024
PeriodQ3 / 2024
EPS Estimate-$0.01
Revenue Estimate27.987M
ChartMill Buy Consensus
48.89%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.78
Upside
+ 4.33%
From current price of $5.54 to mean target of $5.78, Based on 9 analyst forecasts
Low
$5.56
Median
$5.61
High
$6.30
Price Target Revisions
1 Month
0.00%
3 Months
-29.17%
Price Target Summary
9 analysts have analysed ALIM and the average price target is 5.78 USD. This implies a price increase of 4.33% is expected in the next year compared to the current price of 5.54.
The average price target has been revised downward by 29.17% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
48.89%
ALIM was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about ALIM.
In the previous month the buy percentage consensus was at a similar level.
ALIM was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-06-25 | Alliance Global Partners | Downgrade | Buy -> Neutral |
| 2024-06-25 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-06-25 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-25 | Maxim Group | Initiate | Buy |
| 2024-03-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-12 | Alliance Global Partners | Upgrade | Neutral -> Buy |
| 2023-05-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-23 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-21 | Alliance Global Partners | Downgrade | Buy -> Neutral |
| 2022-07-28 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-10 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-25 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-15 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateOct 24, 2024
PeriodQ3 / 2024
EPS Estimate-$0.01
Revenue Estimate27.987M
Revenue Q2Q19.79%
EPS Q2Q83.00%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.26%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
ALIM is expected to report earnings on 10/24/2024. The consensus EPS estimate for the next earnings is -0.01 USD and the consensus revenue estimate is 27.99M USD.
The next earnings revenue estimate has been revised downward by 0.26% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 59.03M 16.16% | 54.13M -8.30% | 80.754M 49.19% | 108.13M 33.90% | 123.51M 14.22% | 138.63M 12.24% | 195.32M 40.89% | 234.04M 19.82% | 278.83M 19.14% | 330.9M 18.67% | 391.74M 18.39% | |
| EBITDA YoY % growth | 2.38M 9.17% | -8.93M -475.21% | 6.815M 176.32% | 21.502M 215.51% | 34.073M 58.46% | 47.699M 39.99% | 90.128M 88.95% | 120.4M 33.59% | 155.62M 29.25% | 196.78M 26.45% | 245.11M 24.56% | |
| EBIT YoY % growth | -200K 60.00% | -11.64M -5,720.00% | -1.932M 83.40% | 5.06M 361.90% | 19.705M 289.43% | 33.412M 69.56% | 72.891M 118.16% | 102.83M 41.07% | 137.67M 33.88% | 178.4M 29.59% | 226.25M 26.82% | |
| Operating Margin | -0.34% | -21.50% | -2.39% | 4.68% | 15.95% | 24.10% | 37.32% | 43.94% | 49.37% | 53.91% | 57.76% | |
| EPS YoY % growth | -1.10 -4.76% | -2.59 -135.45% | -2.16 16.60% | -0.13 94.02% | 0.19 250.00% | 0.44 126.32% | 1.03 134.88% | 1.59 54.46% | 2.07 30.13% | 2.67 29.06% | 3.38 26.34% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 83.00% | 0.04 158.29% | -0.04 66.00% | 0.02 134.00% | 0.02 300.00% | 0.08 100.00% | -0.01 75.00% | 0.06 200.00% | 0.06 200.00% | 0.12 50.00% |
| Revenue Q2Q % growth | 27.987M 19.79% | 30.545M 16.11% | 25.806M 12.15% | 29.784M 10.31% | 29.58M 5.69% | 33.15M 8.53% | 28.458M 10.28% | 32.844M 10.27% | 32.436M 9.66% | 36.618M 10.46% |
| EBITDA Q2Q % growth | 6.108M -19.22% | 8.978M -5.21% | 3.264M 316.86% | 6.732M 10.34% | 6.528M 6.88% | 9.69M 7.93% | 4.896M 50.00% | 8.67M 28.79% | 8.262M 26.56% | 11.934M 23.16% |
| EBIT Q2Q % growth | 1.978M 6.69% | 5.243M 624.17% | 100.00% | 3.468M 4,603.90% | 3.366M 70.17% | 6.528M 24.51% | 1.836M | 5.712M 64.71% | 5.406M 60.61% | 9.078M 39.06% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
30.12%
EPS Next 5 Year
22.31%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
19.90%
Revenue Next 5 Year
23.81%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
329.62%
EBIT Next 5 Year
187.70%
ALIMERA SCIENCES INC / ALIM Forecast FAQ
Can you provide the average price target for ALIMERA SCIENCES INC stock?
9 analysts have analysed ALIM and the average price target is 5.78 USD. This implies a price increase of 4.33% is expected in the next year compared to the current price of 5.54.
Can you provide the upcoming earnings date for ALIMERA SCIENCES INC?
ALIMERA SCIENCES INC (ALIM) will report earnings on 2024-10-24, after the market close.
Can you provide the consensus estimates for ALIMERA SCIENCES INC next earnings?
The consensus EPS estimate for the next earnings of ALIMERA SCIENCES INC (ALIM) is -0.01 USD and the consensus revenue estimate is 27.99M USD.
What is the number of analysts for ALIM stock?
The number of analysts covering ALIMERA SCIENCES INC (ALIM) is 9.